Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

Current Medical Research and Opinion

Volumn 23, Issue 10, 2007, Pages 2531-2542

  Pascual, Maria Luz G ^a   Fleming, Rosa Rosanna B ^a   Gana, Theophilus J ^b   Vorsanger, Gary J ^c  

^a Biovail Technologies Ltd   (United States)

^b Biopharmatech Consulting Inc   (United States)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Chronic pain; Extended release; Low back pain; Nonmalignant pain; Osteoarthritis; Tramadol

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; IBUPROFEN; PARACETAMOL; TRAMADOL;

ADULT; AGED; ANOREXIA; ARTICLE; BACKACHE; CHRONIC PAIN; COMBINATION CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; INFLUENZA; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NERVOUSNESS; ORTHOSTATIC HYPOTENSION; PRURITUS; RHINOPHARYNGITIS; SIDE EFFECT; SOMNOLENCE; SWEATING; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEAKNESS; XEROSTOMIA;

ANALGESICS, OPIOID; BACK PAIN; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; HUMANS; OSTEOARTHRITIS; PAIN; PLACEBOS; TRAMADOL;

EID: 35649009928     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233179     Document Type: Article

References (42)

1. Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85
2. Altman RA, Hochberg MC, Moskowitz RW, et al. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15
3. Simon LS, Lipman AG, Caudill-Slosberg M, et al. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis, 2nd edn. Glenview, IL: American Pain Society, 2002
4. Katz WA. Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs 1996;52(Suppl 3):39-47
5. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004:CD003726
6. Mattia C, Coluzzi F. Tramadol. Focus on musculoskeletal and neuropathic pain. Minerva Anestesiol 2005;71:565-84
7. ULTRAM® (tramadol hydrochloride tablets) prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2004
8. ULTRAM® ER (tramadol HCl) Extended-Release Tablets prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2006
9. Lai JCK, Sista S, Eradiri O. The pharmacokinetics of novel once daily tramadol hydrochloride extended release tablets in healthy subjects [abstract]. AAPS PharmSci 2003;5:M1071
10. Eradiri O, Sista S, Lai JCK, et al. Bioavailability of extended-release and immediate-release formulations of tramadol HCl [Abstract #126]. J Clin Pharmacol 2006;46
11. Deschamps M, Band PR, Hislop TG, et al. The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine. J Pain Symptom Manage 1992;7:384-92
12. Gambling D, Hughes T, Martin G, et al. A comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery. Anesth Analg 2005;100:1065-74
13. Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59-71
14. Gana TJ, Pascual MLG, Fleming RRB, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391-401
15. A study comparing the effectiveness and safety of extended-release tramadol versus placebo in the treatment of chronic low back pain. Available at: http://www.clinicaltrials.gov/ct/show/NCT00347724. Accessed June 6, 2007
16. Haertzen CA. Addiction Research Center Inventory (ARCI): development of a general drug estimation scale. J Nerv Ment Dis 1965;141:300-7
17. Brady JV, Lukas SE, eds. Testing Drugs for Physical Dependence Potential and Abuse Liability: NIDA Research Monograph 52. Rockville, MD: National Institute on Drug Abuse, 1984
18. Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-94
19. Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev 2006;3:CD005522
20. Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006;3:CD003726
21. Moulin DE. Systemic drug treatment for chronic musculoskeletal pain. Clin J Pain 2001;17:S86-93
22. Whelton A. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Am J Cardiol 2006;97:3-9
23. Scheiman JM. Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases. Drugs 2006;66(Suppl 1):15-21
24. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40:6-9
25. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675-9
26. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32
27. Murthy BP, Skee DM, Danyluk AP, et al. Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol. Curr Med Res Opin 2007;23:275-84
28. Hrachovec JB, Mora M. Reporting of 6-month vs. 12-month data in a clinical trial of celecoxib [letter]. JAMA 2001;286:2398
29. Zacny JP. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl) 2003;165:146-56
30. Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl) 2003;170:242-54
31. Zacny JP, Hill JL, Black ML, et al. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther 1998;286:1197-207
32. Zacny JP, Conley K, Galinkin J. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther 1997;282:1187-97
33. Zacny JP, Conley K, Marks S. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. J Pharmacol Exp Ther 1997;280:1159-69
34. Cicero TJ, Inciardi JA, Adams EH, et al. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf 2005;14:851-9
35. Senay EC, Adams EH, Geller A, et al. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003;69:233-41
36. Farrar JT, Young JP, Jr., LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58
37. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003;25:406-11
38. Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005;64:29-33
39. Kosinski M, Janagap C, Gajria K, et al. Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis. Curr Med Res Opin 2007;23:1615-26
40. Mullican WS, Lacy JR. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther 2001;23:1429-45
41. Ruoff GE, Rosenthal N, Jordan D, et al. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003;25:1123-41
42. McQuay H, Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl 2003;28:19-22